Showing results (101-110 of 204) with videos related to

Sort By:
Pageof 21
Experimental Parasitology|February 23, 2011
Human p38 mitogen-activated protein kinase inhibitor drugs inhibit Plasmodium falciparum replicationMichael J Brumlik, Standwell Nkhoma, Mark J Kious, et al.
Open Forum Infectious Diseases|August 6, 2020
Invasive Aspergillosis as an Under-recognized Superinfection in COVID-19George R Thompson Iii, Oliver A Cornely, Peter G Pappas, et al.
Virulence|June 9, 2016
Repurposing auranofin as an antifungal: In vitro activity against a variety of medically important fungiNathan P Wiederhold, Thomas F Patterson, Anand Srinivasan, et al.
The Journal of Antimicrobial Chemotherapy|December 2, 2017
Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trialDimitrios P Kontoyiannis, Dominik Selleslag, Kathleen Mullane, et al.
Antimicrobial Agents and Chemotherapy|April 1, 2024
Ibrexafungerp is efficacious in a neutropenic murine model of pulmonary mucormycosis as monotherapy and combined with liposomal amphotericin BTeclegiorgis Gebremariam, Sondus Alkhazraji, Yiyou Gu, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics|January 13, 2004
Candida glabrata is an emerging cause of oropharyngeal candidiasis in patients receiving radiation for head and neck cancerSpencer W Redding, Marta C Dahiya, William R Kirkpatrick, et al.
Antimicrobial Agents and Chemotherapy|December 28, 2007
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosisNathan P Wiederhold, Laura K Najvar, Ana C Vallor, et al.
Journal of Clinical Microbiology|February 8, 2003
Multiple patterns of resistance to fluconazole in Candida glabrata isolates from a patient with oropharyngeal candidiasis receiving head and neck radiationSpencer W Redding, William R Kirkpatrick, Stephen Saville, et al.
Pageof 21